• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION RESONATE HF CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION RESONATE HF CRT-D; DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D Back to Search Results
Model Number G547
Device Problems Premature Discharge of Battery (1057); Failure to Capture (1081); Use of Device Problem (1670); Low impedance (2285); Battery Problem (2885); High Capture Threshold (3266)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/06/2023
Event Type  Injury  
Event Description
It was reported that the battery of this recently implanted cardiac resynchronization therapy defibrillator (crt-d) was suspected to be depleting prematurely as a recent longevity estimate indicated approximately two years remaining.It was noted that the right ventricular (rv) lead threshold measurement at implant was 0.4v@0.4ms.At this time, right ventricular autothreshold (rvat) testing was in suspension, right ventricular autocapture (rvac) was unavailable, and rv outputs were 5.0v @ 0.4ms.In addition, rv impedance measurements were low and have been trending downward since implant.A request was made to have data from this device analyzed.Data analysis confirmed the battery appeared to be depleting more quickly than expected.This crt-d system remains in service, however urgent device replacement was recommended.This patient is not pacer dependent, and no adverse patient effects were reported.
 
Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.
 
Event Description
It was reported that the battery of this recently implanted cardiac resynchronization therapy defibrillator (crt-d) was suspected to be depleting prematurely as a recent longevity estimate indicated approximately two years remaining.It was noted that the right ventricular (rv) lead threshold measurement at implant was 0.4v@0.4ms.At this time, right ventricular auto threshold (rvat) testing was in suspension, right ventricular autocapture (rvac) was unavailable, and rv outputs were 5.0v @ 0.4ms.In addition, rv impedance measurements were low and have been trending downward since implant.A request was made to have data from this device analyzed.Data analysis confirmed the battery appeared to be depleting more quickly than expected.This crt-d system remains in service, however urgent device replacement was recommended.This patient is not pacer dependent, and no adverse patient effects were reported.Additional information received reported that this cardiac resynchronization therapy defibrillator (crt-d) was explanted, replaced, and returned for analysis.No additional adverse patient effects were reported.
 
Manufacturer Narrative
If pertinent information is provided in the future, a supplemental report will be submitted.The product has been received for analysis.This report will be updated upon completion of analysis.
 
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, a thorough evaluation of the product was performed.Review of device memory confirmed the presence of a higher than normal current drain condition.Electrical testing and analysis were then conducted, which isolated the high current to an anomaly in an oxide layer within a custom integrated circuit component.This anomaly caused a high current drain, which over time resulted in the reported clinical observations.
 
Event Description
It was reported that the battery of this recently implanted cardiac resynchronization therapy defibrillator (crt-d) was suspected to be depleting prematurely as a recent longevity estimate indicated approximately two years remaining.It was noted that the right ventricular (rv) lead threshold measurement at implant was 0.4v@0.4ms.At this time, right ventricular autothreshold (rvat) testing was in suspension, right ventricular autocapture (rvac) was unavailable, and rv outputs were 5.0v @ 0.4ms.In addition, rv impedance measurements were low and have been trending downward since implant.A request was made to have data from this device analyzed.Data analysis confirmed the battery appeared to be depleting more quickly than expected.This crt-d system remains in service, however urgent device replacement was recommended.This patient is not pacer dependent, and no adverse patient effects were reported.Additional information received reported that this cardiac resynchronization therapy defibrillator (crt-d) was explanted, replaced, and returned for analysis.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESONATE HF CRT-D
Type of Device
DEFIBRILLATOR, AUTOMATIC IMPLANTABLE CARDIOVERTER, WITH CRT-D
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
4100 hamline avenue north
saint paul MN 55112
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
cashel road
clonmel
EI  
Manufacturer Contact
timothy degroot
4100 hamline avenue north
saint paul, MN 55112
6515826168
MDR Report Key17355932
MDR Text Key319559120
Report Number2124215-2023-38225
Device Sequence Number1
Product Code NIK
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional
Reporter Occupation Physician
Remedial Action Replace
Type of Report Initial,Followup,Followup
Report Date 02/19/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/19/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Model NumberG547
Device Catalogue NumberG547
Device Lot Number301787
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Date Manufacturer Received02/15/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/02/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
Patient SexFemale
-
-